BIO-TECHNE Corp: financing cash flow
Financing cash flow for BIO-TECHNE Corp. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BIO-TECHNE Corp financial histories
What this measure means
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
Exact concept: us-gaap:NetCashProvidedByUsedInFinancingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2008-07-01 to 2026-06-30. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-07-01 | 2026-06-30 | -169,114,000 | USD | 2026-08-24 | 10-K · 0001104659-26-100322 |
| 2024-07-01 | 2025-06-30 | -253,905,000 | USD | 2026-08-24 | 10-K · 0001104659-26-100322 |
| 2023-07-01 | 2024-06-30 | -122,398,000 | USD | 2026-08-24 | 10-K · 0001104659-26-100322 |
| 2022-07-01 | 2023-06-30 | 22,616,000 | USD | 2025-08-22 | 10-K · 0001558370-25-011716 |
| 2021-07-01 | 2022-06-30 | -242,853,000 | USD | 2024-08-22 | 10-K · 0001558370-24-012430 |
| 2020-07-01 | 2021-06-30 | -62,551,000 | USD | 2023-08-23 | 10-K · 0001558370-23-015226 |
| 2019-07-01 | 2020-06-30 | -183,802,000 | USD | 2022-08-24 | 10-K · 0001558370-22-013935 |
| 2018-07-01 | 2019-06-30 | 134,384,000 | USD | 2021-08-25 | 10-K · 0001437749-21-020980 |
| 2017-07-01 | 2018-06-30 | -99,188,000 | USD | 2020-08-26 | 10-K · 0001437749-20-018754 |
| 2016-07-01 | 2017-06-30 | 189,113,000 | USD | 2019-11-06 | 10-K/A · 0001437749-19-021760 |
| 2015-07-01 | 2016-06-30 | -23,370,000 | USD | 2018-08-27 | 10-K · 0001437749-18-016190 |
| 2012-07-01 | 2013-06-30 | -44,677,000 | USD | 2013-08-29 | 10-K · 0001193125-13-351961 |
| 2011-07-01 | 2012-06-30 | -64,625,000 | USD | 2013-08-29 | 10-K · 0001193125-13-351961 |
| 2010-07-01 | 2011-06-30 | -36,288,000 | USD | 2013-08-29 | 10-K · 0001193125-13-351961 |
| 2009-07-01 | 2010-06-30 | -50,511,000 | USD | 2012-08-29 | 10-K · 0001193125-12-373084 |
| 2008-07-01 | 2009-06-30 | -119,444,000 | USD | 2011-08-29 | 10-K · 0001193125-11-235045 |
Related financial histories
- BIO-TECHNE Corp: total assets
- BIO-TECHNE Corp: stockholders equity
- BIO-TECHNE Corp: cash and cash equivalents
- BIO-TECHNE Corp: net income or loss
- BIO-TECHNE Corp: operating cash flow
- BIO-TECHNE Corp: capital expenditure payments
- BIO-TECHNE Corp: revenue
- BIO-TECHNE Corp: contract revenue excluding tax
- BIO-TECHNE Corp: investing cash flow
- BIO-TECHNE Corp: retained earnings or deficit
- BIO-TECHNE Corp: basic weighted-average shares
- BIO-TECHNE Corp: diluted weighted-average shares
- BIO-TECHNE Corp: basic earnings per share
- BIO-TECHNE Corp: diluted earnings per share
- BIO-TECHNE Corp: income tax expense or benefit
- BIO-TECHNE Corp: net property, plant and equipment
- BIO-TECHNE Corp: share-based compensation expense
- BIO-TECHNE Corp: operating income or loss
- BIO-TECHNE Corp: current assets
- BIO-TECHNE Corp: interest expense
- BIO-TECHNE Corp: current liabilities
- BIO-TECHNE Corp: current accounts payable
- BIO-TECHNE Corp: goodwill carrying amount
- BIO-TECHNE Corp: net finite-lived intangible assets
- BIO-TECHNE Corp: net current accounts receivable
- BIO-TECHNE Corp: common-stock repurchase payments
- BIO-TECHNE Corp: operating expenses
- BIO-TECHNE Corp: net inventory
- BIO-TECHNE Corp: gross profit
- BIO-TECHNE Corp: selling, general and administrative expense
Inspect the source
- Entity
- BIO-TECHNE Corp / CIK 0000842023
- Captured
- 2026-09-19T15:09:12.587Z
- SEC response SHA-256
5f064cd631289049236c7ddafd76f1bc2824b0b55936587bf5e0bb2cc7a0f677
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000842023.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))